Last edition
News about "BELLUS Health Convenes Virtual KOL Meeting to Disc"
BELLUS Health Convenes Virtual KOL Meeting to Discuss the State of Chronic Cough Treatment
Bellus a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that it will convene a virtual Key Opinion Leader (KOL) meeting to discuss the chronic cough landscape on Wednesday, May 27, 2020 at 9:00 a.m. EDT
BELLUS Health Convenes Virtual KOL Meeting To Disc | 15/05/2020 | By Darshana | 298
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy